
|Videos|November 13, 2021
LUGPA 2021: Dr. Chad Ellimoottil on telemedicine
Author(s)Urology Times staff
“Telehealth really helped salvage some of the care that was deferred during the early part of the pandemic, and it’s really here to stay,” says Chad Ellimoottil, MD, MS.
Advertisement
In this video from the 2021 LUGPA annual meeting, Chad Ellimoottil, MD, MS, discusses the COVID-19 pandemic’s impact on telemedicine uptake among urologists as well as how he prepares differently for a telemedicine vs an in-person appointment. Ellimoottil is Assistant Professor of Urology and Director of the University of Michigan’s Telehealth Research Incubator.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
4
ACOU085 shows promise for cisplatin-induced hearing loss in patients with testicular cancer
5











